The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD

Size: px
Start display at page:

Download "The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD"

Transcription

1 The 5 Most Important Things You Need to Know About Atrial Fibrillation John D. Day, MD

2 Disclosures Consulting with St. Jude Medical, Boston Scientific, and Biotronik

3 The 5 Most Important Things You Need to Know About Atrial Fibrillation 1. Lifestyles cause, prevent, or reverse AF 2. Dementia may be the real risk of AF 3. AF drugs aren t perfect 4. Ablation often curative in early AF 5. Must change lifestyle for late AF ablations

4 Global AF/Flutter Burden Chugh et al. Circulation. 2014;129:

5 Global Obesity Burden World Health Organization, 2011

6 Asia vs. North America Incidence per 100,000 Person-years Women Men Men 8x 0 Asia North America Women 10x Chugh et al. Circulation. 2014;129:

7 Incidence of AF in California Medicare patients per 1,000 Person Years 13,967,949 patients 375,318 incident AF episodes over 3.2 years White Black Hispanic Asian Circulation Dec 3;128(23):2470-7

8 Some Physical Activity ~50% Reduction n = 14,219 Circ Arrhythm Electrophysiol. 2014;7:

9 Yoga: 24% Reduction JACC Vol. 61, No. 11, 2013 March 19, 2013:

10

11 How Important is Losing 36 Pounds? 46% of A-Fib patients went into remission Systolic blood pressure down 18 mmhg Inflammation decreased 76% (CRP) Diabetes into remission: 88% LDL down 16%, triglycerides 31% Heart disease reversed Well being up 200%!

12 The 5 Most Important Things You Need to Know About Atrial Fibrillation 1. Lifestyles cause, prevent, or reverse AF 2. Dementia may be the real risk of AF 3. AF drugs aren t perfect 4. Ablation often curative in early AF 5. Must change lifestyle for late AF ablations

13 Heart Rhythm 2010;7:

14 p< No Atrial Fibrillation Atrial Fibrillation 37,026 patients, 5 years follow-up Incidence (%) MRI/neurologist confirmed diagnosis AF + Alzheimer s rapid decline p< p< p< Dementia Type Heart Rhythm 2010;7:

15 Dementia and Alzheimer's Disease Odds Ratio Increased Risk Age (years) Heart Rhythm 2010;7:

16 Is 5 years of data enough???

17 Cognitive Changes Immediately No Afib Paroxysmal Afib Persistent Afib J Am Coll Cardiol 2013;62:1990 7

18 The 5 Most Important Things You Need to Know About Atrial Fibrillation 1. Lifestyles cause, prevent, or reverse AF 2. Dementia may be the real risk of AF 3. AF drugs aren t perfect 4. Ablation often curative in early AF 5. Must change lifestyle for late AF ablations

19 How good are antiarrhythmics? 100 Patients without recurrence (%) Amiodarone Sotalol Propafenone/flecainide Dofetilide Dronedarone Follow-up (days) Circulation 2000, 102: , J Cardiovasc Electrophysiol, 2010; Vol. 21, pp

20 Definition: 2 units PRBCs at a critical site or death Brain, eye, spine, joint, pericardium, retroperitoneal 18,140 patients, average CHADS score of 2.1 Warfarin: 3.09% per year Apixaban: 2.13% per year J Am Coll Cardiol 2014;63:2141 7

21 Cerebral Microbleeds Lancet Neurol Feb;8(2):165-74

22 Annual Warfarin Microbleeds Charidimou, Front Neurol, 2012

23 Reverse CHADS-VASc Score 2014 AHA/ACC/HRS Atrial Fibrillation Treatment Guidelines

24 The 5 Most Important Things You Need to Know About Atrial Fibrillation 1. Lifestyles cause, prevent, or reverse AF 2. Dementia may be the real risk of AF 3. AF drugs aren t perfect 4. Ablation often curative in early AF 5. Must change lifestyle for late AF ablations

25 Ablation Success by Fibrosis 329 patients, 15 centers 85% 68% 54% 31% DEECAF Multicenter Study: JAMA. 2014;311(5):

26 AF Begets AF Fast... Electrical remodeling within 30 minutes Fibrosis within 5 weeks Circulation 1996;94: , Circulation 1999;100:87-95

27 AF Diagnosis to Ablation: Success Rates 82% 81% 80% 79% 78% 77% 76% 75% 74% 73% 72% 1-3 months 3-12 months > 1 year 81% 77% 75% Ablation Success Heart Rhythm Sep;10(9):

28 The 5 Most Important Things You Need to Know About Atrial Fibrillation 1. Lifestyles cause, prevent, or reverse AF 2. Dementia may be the real risk of AF 3. AF drugs aren t perfect 4. Ablation often curative in early AF 5. Must change lifestyle for late AF ablations

29 Lifestyle Medicine Improves Acute Success One Ablation 2 Ablations 100% 80% 60% 40% 20% 0% 87% 48% 62% 26% Lifesyle Changes No Changes n = Ablations One Ablation 2014 Annual Scientific Sessions of Heart Rhythm Society

30 Will lowering BMI improve long-term success? J Interv Card Electrophysiol Sep;46(3):259-65

31 A Lower BMI Improves Success n = 1,558

32 Losing Weight Improves Success n = 1,558

33 BMI and Long-term Success 1. Optimal BMI was Any weight loss improves success 3. Most high BMIs recur long-term 4. BMI < 20 have a high risk of CV death J Interv Card Electrophysiol Sep;46(3):259-65

34 Questions? Mobile: facebook.com/drjohnday

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD Director, Intermountain Heart Rhythm Specialists

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD Director, Intermountain Heart Rhythm Specialists The 5 Most Important Things You Need to Know About Atrial Fibrillation John D. Day, MD Director, Intermountain Heart Rhythm Specialists None Disclosures The 5 Most Important Things You Need to Know About

More information

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance

More information

Updates in Atrial Fibrillation

Updates in Atrial Fibrillation Updates in Atrial Fibrillation Michael Curley, MD Cardiac Electrophysiologist Wheaton Franciscan Medical Group #1 Most common heart rhythm disturbance 1 in 4 Americans over 40 will be diagnosed 3,500,000

More information

Innovations in AF Management

Innovations in AF Management Innovations in AF Management Barry Boilson MD PhD FRCPI boilson.barry@mayo.edu Disclosures Relevant None financial relationship(s) with industry None Off Label Usage None Overview Mechanisms of AF AF as

More information

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital Rate control versus Rhythm control for Atrial Fibrillation AFFIRM N Engl J Med 2002;347:1825-33

More information

Does AF Ablation Lower Stroke Risk? Hugh Calkins MD Professor of Medicine Director of Electrophysiology Johns Hopkins Medical Institutions

Does AF Ablation Lower Stroke Risk? Hugh Calkins MD Professor of Medicine Director of Electrophysiology Johns Hopkins Medical Institutions Does AF Ablation Lower Stroke Risk? Hugh Calkins MD Professor of Medicine Director of Electrophysiology Johns Hopkins Medical Institutions Relationships! Consultant: Medtronic, St Jude, Atricure, Boherringer

More information

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Rhythm control antiarrhythmic drugs vs catheter ablation Summary

More information

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist Are Drugs Better? Drugs or ablation as first line treatment for AF? Dr Mauro Lencioni Consultant Cardiologist & Electrophysiologist The Philosophical Issue What do we mean by Better? Outcome measures Measurement

More information

ATRIAL FIBRILLATION AROUND THE WORLD/ CONTINENTAL PERSPECTIVES AND SPECIFICITIES: SOUTH AMERICA. LUIS AGUINAGA MD, PhD, FESC,FACC Argentina

ATRIAL FIBRILLATION AROUND THE WORLD/ CONTINENTAL PERSPECTIVES AND SPECIFICITIES: SOUTH AMERICA. LUIS AGUINAGA MD, PhD, FESC,FACC Argentina ATRIAL FIBRILLATION AROUND THE WORLD/ CONTINENTAL PERSPECTIVES AND SPECIFICITIES: SOUTH AMERICA LUIS AGUINAGA MD, PhD, FESC,FACC Argentina 2010 Global Burden of Disease Study Chugh, S. S. et al. Circulation,

More information

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation 48 th Annual New York Cardiovascular Symposium Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation Is Left Atrial Appendage Dysfunction Sufficient to Generate Clots? December

More information

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015 AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015 Disclosures Research grant: St. Jude medical Speaking: Boehringer-Ingelheim Consulting: Arca Biopharma Learning

More information

Modest Medtronic. Modest Boehringer Ingelheim

Modest Medtronic. Modest Boehringer Ingelheim Adults With AF (millions) Modest Medtronic Modest Boehringer Ingelheim Changing Modalities of Care for Atrial Fibrillation Jill Repoley MSN, CRNP, CCDS, CEPS, FHRS 7 6 5 4 3 2 1 2.08 2.26 2.44 2.66 2.94

More information

ATRIAL FIBRILLATION: IS IT REALLY TYPE 2 DIABETES MASQUERADING AS CARDIAC MISFORTUNE?

ATRIAL FIBRILLATION: IS IT REALLY TYPE 2 DIABETES MASQUERADING AS CARDIAC MISFORTUNE? ATRIAL FIBRILLATION: IS IT REALLY TYPE 2 DIABETES MASQUERADING AS CARDIAC MISFORTUNE? ROBERT M PEPPER, DO, FAAFP ASSISTANT DEAN OF PRE DOCTORAL CLINICAL SCIENCES WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE

More information

Left Atrial Appendage Closure: The Rationale

Left Atrial Appendage Closure: The Rationale Left Atrial Appendage Closure: The Rationale JOHN D. HUMMEL, MD DIRECTOR OF CLINCAL ELECTROPHYSIOLOGY RESEARCH PROFESSOR OF CLINICAL INTERNAL MEDICINE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER 1 Disclosures

More information

IS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES?

IS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES? IS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES? ROBERT M PEPPER, DO, FAAFP ASSISTANT DEAN PREDOCTORAL CLINICAL EDUCATION WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE IS ATRIAL FIBRILLATION THE NEXT TYPE

More information

Catheter ablation is not a class I indication after failed antiarrhythmic drugs

Catheter ablation is not a class I indication after failed antiarrhythmic drugs Catheter ablation is not a class I indication after failed antiarrhythmic drugs Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific

More information

Prevention of atrial fibrillation. OPSC Annual Convention Jigar Patel, DO February 18, 2017

Prevention of atrial fibrillation. OPSC Annual Convention Jigar Patel, DO February 18, 2017 Prevention of atrial fibrillation OPSC Annual Convention Jigar Patel, DO February 18, 2017 Disclosures Jannsen speakers bureau (maker of Xarelto) St Jude consulting work Medtronic consulting work Biotronik

More information

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES AF: the kingdom of wishful thinking In AF we

More information

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University

More information

Atrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann

Atrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann Klinikum Coburg Atrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann Prof. Dr. med. J. Brachmann Bologna 16 th February 2017 Disclosures Study Grants: Biotronik, Medtronic, SJM, Abbott,

More information

Spontaneous Atrial Fibrillation and Noacs and Reversal agents

Spontaneous Atrial Fibrillation and Noacs and Reversal agents Spontaneous Atrial Fibrillation and Noacs and Reversal agents Laurent Lewkowiez, MD Regional Service Chief, Hospital Cardiology CPMG Cardiac Electrophysiology Educational Goals relationship between atrial

More information

Half Moon Bay Treatment of Atrial Fibrillation. Dr. Roger A. Winkle MD. Silicon Valley Cardiology, PAMF, Sutter Health Sequoia Hospital

Half Moon Bay Treatment of Atrial Fibrillation. Dr. Roger A. Winkle MD. Silicon Valley Cardiology, PAMF, Sutter Health Sequoia Hospital Half Moon Bay 2018 Treatment of Atrial Fibrillation Dr. Roger A. Winkle MD Silicon Valley Cardiology, PAMF, Sutter Health Sequoia Hospital Disclosures: Investor Farapulse Things a Primary Care Doctor Should

More information

Fibs and Flutters: The Heart of the Matter

Fibs and Flutters: The Heart of the Matter Fibs and Flutters: The Heart of the Matter Anita Ralstin, CNP By the Numbers Atrial Fibrillation Hospital Discharges /quarter for 2012 -- 116,500 Average Length of Stay 4 days Projected that 20% of those

More information

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Atrial Fibrillation and Heart Failure: A Cause or a Consequence Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November

More information

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million

More information

How atrial fibrillation should be treated in the heart failure patient?

How atrial fibrillation should be treated in the heart failure patient? Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 13/15 Ottobre 2016 How atrial fibrillation should be treated in the heart failure patient? Matteo Anselmino Dipartimento Scienze

More information

Mohammad Zubaid, MB, ChB, FRCPC, FACC

Mohammad Zubaid, MB, ChB, FRCPC, FACC Management and one year outcome of atrial fibrillation in Middle Eastern cohort enrolled in the observational Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Mohammad Zubaid, MB, ChB, FRCPC, FACC

More information

Management of atrial fibrillation a holistic view - Prof. Dr. Martin Borggrefe Mannheim

Management of atrial fibrillation a holistic view - Prof. Dr. Martin Borggrefe Mannheim a holistic view - Prof. Dr. Martin Borggrefe Mannheim Patients with atrial fibrillation (millions) 16 14 12 10 8 6 4 2 0 Management of atrial fibrillation Expected prevalence of apparent AF 5,1 5,1 5,9

More information

Rate and Rhythm Control of Atrial Fibrillation

Rate and Rhythm Control of Atrial Fibrillation Rate and Rhythm Control of Atrial Fibrillation April 21, 2017 춘계심혈관통합학술대회 Jaemin Shim, MD, PhD Arrhythmia Center Korea University Anam Hospital Treatment of AF Goal Reducing symptoms Preventing complication

More information

3/25/2017. Program Outline. Classification of Atrial Fibrillation

3/25/2017. Program Outline. Classification of Atrial Fibrillation Alternate Strategies to Antiarrhythmic Therapy: The Role of Ablation Jennifer El Aile, MS, AGPCNP-BC Electrophysiology Nurse Practitioner Clinical Lecturer at the University of Michigan Program Outline

More information

ABLATION OF CHRONIC AF

ABLATION OF CHRONIC AF ABLATION OF CHRONIC AF A PISAPIA ST JOSEPH HOSPITAL MARSEILLE MEET 2008 Atrial Fibrillation The most common significant heart rhythm disturbance Incidence increases with age and the development of structural

More information

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION Frederick Schaller, DO, MACOI,FACP Adjunct Clinical Professor Touro University Nevada DISCLOSURES I have no financial relationships

More information

Atrial Fibrillation New Approaches, Techniques, and Technology

Atrial Fibrillation New Approaches, Techniques, and Technology New Cardiovascular Horizons 2015 May 28, 2015 New Orleans, Louisiana Atrial Fibrillation New Approaches, Techniques, and Technology State of the Art - - 2015 Richard Abben, M D Director, Cardiac Arrhythmia

More information

Saudi Heart Association February 22, 2011

Saudi Heart Association February 22, 2011 Pharmacological Therapy of Atrial Fibrillation: Recent Advances Dr Martin Green Professor of Medicine (Cardiology) University of Ottawa Saudi Heart Association February 22, 2011 Atrial Fibrillation Drugs

More information

Invasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic

Invasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic Invasive and Medical Treatments for Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic Disclosures Fellow s advisory panel for St Jude Medical Speaking honoraria from: Boston

More information

Left atrial Function In Echocardiography

Left atrial Function In Echocardiography Left atrial Function In Echocardiography Pr Erwan DONAL erwan.donal@chu-rennes.fr Inserm Diastole LA Pressure (mmhg) -t/ 17 LA function 15 A-Loop 13 V-Loop 11 9 7 5 1 2 3 4 20 30 40 50 60 70 LA Volume

More information

Atrial Fibrillation and Heart Failure

Atrial Fibrillation and Heart Failure Date Clinical Title Atrial Fibrillation and Heart Failure Raul Weiss MD, FAHA, FACC, FHRS and CCDS Director, Electrophysiology Fellowship Program Professor of Medicine The Ohio State University Wexner

More information

ROLE OF IMAGING IN ARRHYTHMIA/DEVICES I ATRIAL FΙBRILLATION: CLINICAL TYPES AND OUTCOME (PROGNOSIS)

ROLE OF IMAGING IN ARRHYTHMIA/DEVICES I ATRIAL FΙBRILLATION: CLINICAL TYPES AND OUTCOME (PROGNOSIS) ROLE OF IMAGING IN ARRHYTHMIA/DEVICES I ATRIAL FΙBRILLATION: CLINICAL TYPES AND OUTCOME (PROGNOSIS) Κώστας Παπαδόπουλος, Επιμ. Α Καρδιολογίας, Νοσοκομείο Ερυθρός Σταυρός ATRIAL FIBRILATION - EPIDEMIOLOGY

More information

Atrial Fibrillation. Wat ur di-n 2 no. Ned Gutman 6 August, 2009

Atrial Fibrillation. Wat ur di-n 2 no. Ned Gutman 6 August, 2009 Atrial Fibrillation Wat ur di-n 2 no Ned Gutman 6 August, 2009 2 goals in treating AF Alleviation of symptoms Reduce risk of stroke Anticoagulation CHADS score Future anticoagulants Rate vs Rhythm control

More information

Prof. Fiorenzo Gaita

Prof. Fiorenzo Gaita Adavances in Cardiac Arrhythmias and Great Innovations in Cardiology Turin 2014 Can rhythm control strategy reduce the risk of clinical and silent cerebral ischemia? Prof. Fiorenzo Gaita Director of the

More information

Controversies in Atrial Fibrillation and HF

Controversies in Atrial Fibrillation and HF Controversies in Atrial Fibrillation and HF Dr.Yahya Al Hebaishi Cardiac electrophysiology division, PSCC, Riyadh Atrial Fibrillation: Rate or Rhythm? HF and AF: the twin epidemic of cardiovascular disease.

More information

Understanding Atrial Fibrillation Management. Roy Lin, MD

Understanding Atrial Fibrillation Management. Roy Lin, MD Understanding Atrial Fibrillation Management Roy Lin, MD Disclosure None Definition of atrial fibrillation Atrial fibrillation is a supraventricular tachyarrhythmia characterized by uncoordinated atrial

More information

Samer Nasr, M.D. Mount Lebanon Hospital.

Samer Nasr, M.D. Mount Lebanon Hospital. Samer Nasr, M.D. Mount Lebanon Hospital. Lone atrial fibrillation: Younger than 60 years old. No clinical or echo evidence of cardiopulmonary disease. Favorable prognosis. Thromboembolism usually not

More information

When does enhanced monitoring for atrial fibrillation add value?

When does enhanced monitoring for atrial fibrillation add value? When does enhanced monitoring for atrial fibrillation add value? Jonathan P. Piccini, MD, MHS, FHRS Associate Professor of Medicine Duke Clinical Research Institute Duke University Medical Center jonathan.piccini@duke.edu

More information

Postoperative Management of Patients Following Surgical Ablation

Postoperative Management of Patients Following Surgical Ablation Postoperative Management of Patients Following Surgical Ablation Harold G. Roberts, Jr. Department of Cardiovascular and Thoracic Surgery West Virginia University Morgantown, WV None Disclosures Postop

More information

Debate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm

Debate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm ESC ICM - Internationales Congress Center München 2012 Atrial Fibrillation Controversies in Medical Treatment Debate Dronedarone is an important drug in the management of paroxysmal atrial fibrillation

More information

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring Catheter Ablation of Atrial Fibrillation: State of the Art Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring Dipen Shah Service de Cardiologie Hospital Cantonal de Genève

More information

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland Disclosures Research Grants: Biosense Webster, St. Jude, Bard, Endosense, Biotronik Speakers Honoraria: Biosense Webster, Endosense,

More information

Modifiable Up-Stream Risk Factors:

Modifiable Up-Stream Risk Factors: Modifiable Up-Stream Risk Factors: Recent Studies in AF Prevention Behzad Pavri, MD, FACC, FHRS Professor of Medicine Director, CCEP Fellowship Thomas Jefferson University Hospital, Philadelphia, USA Disclosures

More information

심방세동과최신항응고요법 RACE II AFFIRM 항응고치료는왜중요한가? Rhythm control. Rate control. Anticoagulation 남기병 서울아산병원내과. Clinical Impact of Atrial Fibrillation

심방세동과최신항응고요법 RACE II AFFIRM 항응고치료는왜중요한가? Rhythm control. Rate control. Anticoagulation 남기병 서울아산병원내과. Clinical Impact of Atrial Fibrillation 소강당 심방세동과최신항응고요법 남기병 서울아산병원내과 Clinical Impact of Atrial Fibrillation QoL Hospitalization Stroke CHF Mortality 항응고치료는왜중요한가? Rhythm control Rate control Anticoagulation JACC Vol. 38, No. 4, 2001 AFFIRM RACE

More information

FA et Apnée du Sommeil

FA et Apnée du Sommeil FA et Apnée du Sommeil La Réunion Octobre 2017 Pascal Defaye CHU Grenoble-Alpes Obstructive Sleep Apnea and AF Incidence of atrial fibrillation (AF), based on presence or absence of OSA. Cumulative frequency

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Table S1 Sex- specific differences in rate- control and rhythm- control strategies in observational studies Study region Study period Total sample size Sex- specific results Ozcan (2001) 1 Mayo Clinic,

More information

Subclinical AF: Implications of device based episodes

Subclinical AF: Implications of device based episodes Subclinical AF: Implications of device based episodes Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting: Medtronic, Boston Scientific

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Outcomes of AF Ablation

Outcomes of AF Ablation 2017 춘계심혈관통합학술대회 AF Summit: Atrial Fibrillation Apr.21(Fri) 14:40-16:10 Rm.300B 15:00-15:10 Outcomes of AF Ablation Gi-Byoung Nam MD Asan Medical Center, UUCM 2017 Annual Spring Scientific Conference of

More information

In Whom and When Should Atrial Fibrillation Ablation be Considered?

In Whom and When Should Atrial Fibrillation Ablation be Considered? In Whom and When Should Atrial Fibrillation Ablation be Considered? Christian de Chillou, MD, PhD Department of Cardiology University Hospital Nancy, France ESC 2010 Stockholm, August 30. 2010 2 In Whom?

More information

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United

More information

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Matteo Anselmino Division of Cardiology Città della Salute e della Scienza Hospital University of Turin, Italy Disclosure: Honoraria

More information

What s New in the AF Guidelines

What s New in the AF Guidelines Impact on New AF Guidelines on Heart Failure Management Gothenburg - May 22 nd 2011 Europace (2010) 12, 1360-420 http://europace.oxfordjournals.org JACC (2011) 57, 223-42 http://www.cardiosource.org What

More information

Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond

Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond John M. Miller, MD Professor of Medicine Indiana University School of Medicine Director, Clinical Cardiac Electrophysiology Krannert

More information

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire AF and arrhythmia management Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire Atrial fibrillation Paroxysmal AF recurrent AF (>2 episodes) that

More information

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

Indicatie voor ablatie bij voorkamerfibrillatie. Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen Indicatie voor ablatie bij voorkamerfibrillatie Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen Definition and Classification of AF - Practical aspects Classification of AF Paroxysmal, persistent,

More information

Interventional solutions for atrial fibrillation in patients with heart failure

Interventional solutions for atrial fibrillation in patients with heart failure Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department

More information

Atrial Fibrillation What are the Options in 2016?

Atrial Fibrillation What are the Options in 2016? Atrial Fibrillation What are the Options in 2016? David Spragg, MD, FHRS Johns Hopkins Hospital Cardiovascular Disease Management October, 2016 Disclosures Consulting, Biosense Webster Overview What is

More information

When to ablate patients with premature ventricular complexes?

When to ablate patients with premature ventricular complexes? When to ablate patients with premature ventricular complexes? Nikolaos Fragakis Assistant Professor, FESC 3rd University Cardiology Department Hippokration Hospital, Thessaloniki 58 year-old female Case

More information

MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION December 9, 2017

MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION December 9, 2017 MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION December 9, 2017 1 Faculty Disclosure Faculty: Peter Leong-Sit MSc, MD, FRCPC, FHRS Associate Professor, Western University Cardiologist, London Heart

More information

Ablation of persistent AF Is it different than paroxysmal?

Ablation of persistent AF Is it different than paroxysmal? Ablation of persistent AF Is it different than paroxysmal? Steven J. Kalbfleisch, MD Medical Director Electrophysiology Laboratory Ohio State University Wexner Medical Center Ross Heart Hospital Columbus,

More information

Atrial Fibrillation: Interventional Approaches

Atrial Fibrillation: Interventional Approaches Atrial Fibrillation: Interventional Approaches Tyler Taigen, MD Eric Espinal, MD Discussion Outline Review current treatment of atrial fibrillation Pathophysiology Risk assessment and treatment to reduce

More information

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P. Ioannina 2015 Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method Konstantinos P. Letsas, MD, FESC SECOND DEPARTMENT OF CARDIOLOGY LABORATORY

More information

NEW APPROACHES AND NEW ANTICOAGULANTS FOR ATRIAL FIBRILLATION

NEW APPROACHES AND NEW ANTICOAGULANTS FOR ATRIAL FIBRILLATION NEW APPROACHES AND NEW ANTICOAGULANTS FOR ATRIAL FIBRILLATION MAY 1, 2015 Melissa R. Robinson, MD FACC FHRS CCDS Assistant Professor of Medicine Director of the Complex Arrhythmia Service POINTS TO MAKE

More information

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT 5-2014 Atrial Fibrillation therapeutic Approach Rhythm Control Thromboembolism Prevention: Recommendations Direct-Current

More information

Role of class 1C AAD revisited

Role of class 1C AAD revisited Role of class 1C AAD revisited Juan Tamargo Department of Pharmacology, School of Medicine Universidad Complutense, Madrid, Spain Conflict of interest: I am a Pharmacologist Prevalence of AF in Spain OFRECE

More information

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On? The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On? L. Pison, MD PhD FESC AATS Surgical Treatment of Arrhythmias and Rhythm Disorders November 17-18, 2017 Miami Beach, FL, USA

More information

HF and CRT: CRT-P versus CRT-D

HF and CRT: CRT-P versus CRT-D HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA

More information

Atrial Cardiomyopathy is it relevant?

Atrial Cardiomyopathy is it relevant? Atrial Cardiomyopathy is it relevant? Dr Carl Shakespeare MD FRCP FACC FESC Consultant Cardiologist Relevance Progressive nature of AF Implications for RF Targeting Risk Factors CHADS vasc scoring? Could

More information

Atrial Fibrillation and Common Supraventricular Tachycardias. Sunil Kapur MD

Atrial Fibrillation and Common Supraventricular Tachycardias. Sunil Kapur MD Atrial Fibrillation and Common Supraventricular Tachycardias Sunil Kapur MD Cardiac Electrophysiology Brigham and Women s Hospital Instructor, Harvard Medical School No disclosures Cardiac Conduction:

More information

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist 2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist Todays Objectives Atrial Fibrillation evaluation and treatment from an EP perspective Multimodal

More information

Fibrillazione Atriale Fattore di Rischio o Marker di Stroke: Implicazioni Per La Terapia

Fibrillazione Atriale Fattore di Rischio o Marker di Stroke: Implicazioni Per La Terapia Gianluca Botto, FESC Elettrofisiologia Ospedale Sant Anna, Como Fibrillazione Atriale Fattore di Rischio o Marker di Stroke: Implicazioni Per La Terapia 20 min Presenter Disclosure Information n n n Research

More information

Conflicts of Interests

Conflicts of Interests Advances in the Management of Atrial Fibrillation State of the Art in 2013 Overview of AF Stroke risk and anticoagulation Rate control Antiarrhythmic Drug Therapy Catheter ablation Conclusion Hugh Calkins

More information

Is Atrial Fibrillation preventable?

Is Atrial Fibrillation preventable? Heart Rhythm Congress, Birmingham, 11 th October 2016 Is Atrial Fibrillation preventable? The interplay between genetic and environmental factors in genesis of AF Andrew Grace University of Cambridge -

More information

Patient Presentation

Patient Presentation Update on Current Perspectives and Management Options for Atrial Fibrillation Burr Hall, M.D. March 20, 2015 Patient Presentation 72 year old active male farmer and tow truck operator from Hemlock, NY

More information

Patient with high risk for bleeding

Patient with high risk for bleeding Will Apixaban change practice in atrial fibrillation Luncheon Satellite Sponsored by Pfizer Patient with high risk for bleeding Prof. Amos Katz M.D August 2012: patient background 67-year-old woman History

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A AADs. See Antiarrhythmic drugs (AADs) ACE inhibitors. See Angiotensin-converting enzyme (ACE) inhibitors ACP in transseptal approach to

More information

Geriatric Grand Rounds

Geriatric Grand Rounds Geriatric Grand Rounds Tuesday, April 13, 21 12: noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this

More information

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Alessandria, September 23 th 2017 Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Professor Fiorenzo Gaita Chief of the Cardiovascular Department Città della Salute e della Scienza

More information

Recent observations have focused attention on the PVs as a source of ectopic activity i determining i AF

Recent observations have focused attention on the PVs as a source of ectopic activity i determining i AF Atrial Fibrillation in 2010 Panos Vardas Professor of Cardiology President of EHRA Atrial Fibrillation Pathophysiology of AF Triggers Recent observations have focused attention on the PVs as a source of

More information

Possible clinical and hemodynamic predictors of atrial fibrillation recurrence after catheter ablation

Possible clinical and hemodynamic predictors of atrial fibrillation recurrence after catheter ablation Samara Regional Center of Cardiosurgery Possible clinical and hemodynamic predictors of atrial fibrillation recurrence after catheter ablation S. Dolginina, S. Garkina, S. Khokhlunov, D. Duplyakov Russia

More information

Stuart Beldner, MD, FHRS Assistant Professor NSLIJ Hofstra School of Med

Stuart Beldner, MD, FHRS Assistant Professor NSLIJ Hofstra School of Med Stuart Beldner, MD, FHRS Assistant Professor NSLIJ Hofstra School of Med None There s no reason to panic. While it is true that one of the crew members is ill, slightly. Absence of discrete P waves Chaotic

More information

Long-Term Atrial Fibrillation Progression: What We Know in 2014

Long-Term Atrial Fibrillation Progression: What We Know in 2014 Long-Term Atrial Fibrillation Progression: What We Know in 2014 Advances in Cardiac Arrhythmias and Great Innovations in Cardiology XXVI Giornate Cardiologiche Torinesi Turin, 23-25 October 2014 Davide

More information

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center Radiofrequency Ablation of Atrial Fibrillation: Comparison of Success Rate of Circular Ablation vs Point-by-Point Ablation with Contact Force Assessment in Paroxysmal and Persistent Atrial Fibrillation

More information

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Joseph de Bono Consultant Electrophysiologist University Hospitals Birmingham Atrial Fibrillation (AF) Affects 2% of the

More information

Current Guideline for AF Treatment. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

Current Guideline for AF Treatment. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Current Guideline for AF Treatment Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Case 1 59 year-old lady Sudden palpitation and breathlessness for 12 hours

More information

Rate or Rhythm Control? Epidemiology. Relevant Advances in Atrial Fibrillation 6/20/2011. Stroke Prophylaxis

Rate or Rhythm Control? Epidemiology. Relevant Advances in Atrial Fibrillation 6/20/2011. Stroke Prophylaxis Relevant Advances in Atrial Fibrillation Stroke Prophylaxis Managing Atrial Fibrillation: Tips for the Generalist Antiarrhythmic Drug Therapy Ablation Gregory M Marcus, MD, MAS Assistant Professor of Medicine

More information

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC AF Clinical/Referral Challenge Asymptomatic 40% 3 Rx Effective 30% Failed Rx Ablation Atrial fibrillation (AF) is the most common Candidate

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): a randomzied clinical

More information

ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΗΛΕΚΤΡΙΚΗ ΑΝΑΤΑΞΗ. ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ Καρδιολόγος, Ε/Α, Γ.Ν.Κατερίνης. F.E.S.C

ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΗΛΕΚΤΡΙΚΗ ΑΝΑΤΑΞΗ. ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ Καρδιολόγος, Ε/Α, Γ.Ν.Κατερίνης. F.E.S.C ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΗΛΕΚΤΡΙΚΗ ΑΝΑΤΑΞΗ ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ Καρδιολόγος, Ε/Α, Γ.Ν.Κατερίνης. F.E.S.C Definitions of AF: A Simplified Scheme Term Definition Paroxysmal AF AF that terminates

More information

A MULTIDISCIPLINARY APPROACH TO ATRIAL FIBRILLATION: OUR EXPERIENCE WITH THE CONVERGENT PROCEDURE

A MULTIDISCIPLINARY APPROACH TO ATRIAL FIBRILLATION: OUR EXPERIENCE WITH THE CONVERGENT PROCEDURE A MULTIDISCIPLINARY APPROACH TO ATRIAL FIBRILLATION: OUR EXPERIENCE WITH THE CONVERGENT PROCEDURE Joe Aoun, MD Ioannis Koulouridis, MD, MSc Aleem Mughal, MD Maxwell Eyram Afari, MD Caroline Zahm, MD John

More information

Rajeev K. Pathak MBBS, PhD. Department of Cardiac Electrophysiology Hospital of University of Pennsylvania

Rajeev K. Pathak MBBS, PhD. Department of Cardiac Electrophysiology Hospital of University of Pennsylvania Rajeev K. Pathak MBBS, PhD Department of Cardiac Electrophysiology Hospital of University of Pennsylvania Nil Applicable Disclosure Proportion overweight 70% 60% 50% 40% USA Australia England 30% France

More information

AF Ablation in Patients with Heart Failure

AF Ablation in Patients with Heart Failure AF Ablation in Patients with Heart Failure Christian de Chillou, MD, PhD Department of Cardiology University Hospital Nancy, France 28ème Journée Internationale du Centre Cardio-Thoracique de Monaco Monaco,

More information

DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica

DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica Corso Multidisciplinare di Aggiornamento La Sindrome delle Apnee Notturne: una sfida diagnostico terapeutica DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica FRANCESCO PERNA, MD, PhD Laboratorio

More information